The document provides guidelines for the management of patients presenting without persistent ST-segment elevation myocardial infarction (NSTE-ACS). It includes recommendations for diagnosis using high-sensitivity cardiac troponin assays, risk stratification, imaging, and rhythm monitoring. It also provides guidance on pharmacological treatment including beta blockers, antiplatelet and anticoagulation therapy. Recommendations are given for invasive coronary angiography and revascularization based on risk criteria. The guidelines further address management of special patient groups and long-term management after NSTE-ACS.
The document provides guidelines for the management of patients presenting without persistent ST-segment elevation myocardial infarction (NSTE-ACS). It includes recommendations for diagnosis using high-sensitivity cardiac troponin assays, risk stratification, imaging, and rhythm monitoring. It also provides guidance on pharmacological treatment including beta blockers, antiplatelet and anticoagulation therapy. Recommendations are given for invasive coronary angiography and revascularization based on risk criteria. The guidelines further address management of special patient groups and long-term management after NSTE-ACS.
The document provides guidelines for the management of patients presenting without persistent ST-segment elevation myocardial infarction (NSTE-ACS). It includes recommendations for diagnosis using high-sensitivity cardiac troponin assays, risk stratification, imaging, and rhythm monitoring. It also provides guidance on pharmacological treatment including beta blockers, antiplatelet and anticoagulation therapy. Recommendations are given for invasive coronary angiography and revascularization based on risk criteria. The guidelines further address management of special patient groups and long-term management after NSTE-ACS.
persistent ST-segment elevation DIAGNOSIS Differential diagnoses of acute coronary syndromes in the setting of acute chest pain 0 h/3 h rule-out algorithm of non-ST-elevation acute coronary syndromes using high-sensitivity cardiac troponin assays. . Recommendations for Diagnosis, Risk Stratification, Imaging And Rhytm Monitoring in Patient with NSTE ACS Pharmacological Treatment of Ischemia Beta Blocker Platelet Inhibition Recommendations for platelet inhibition in non-STelevation acute coronary syndromes Anticoagulation Recommendations for combining antiplatelet agents and anticoagulants in non-ST-elevation acute coronary syndrome patients requiring chronic oral anticoagulation Antithrombotic strategies in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) and non-valvular atrial fibrillation. Suggested strategies to reduce bleeding risk related to PCI Recommendations for bleeding management and blood transfusion in non-ST-elevation acute coronary syndromes Invasive Coronary Angiography & Revascularization Risk criteria mandating invasive strategy in NSTE-ACS Selection of non-ST-elevation acute coronary syndromes (NSTE- ACS) treatment strategy and timing according to initial risk stratification Recommendations for invasive coronary angiography and revascularization in NSTE ACS Recommendations for perioperative management of antiplatelet therapy in non-ST-elevation acute coronary syndrome patients requiring coronary artery bypass surgery Recommendations for the management of elderly patients with non-ST-elevation acute coronary syndromes Recommendations for the management of diabetic patients with non-ST-elevation acute coronary syndromes Recommendations for the management of patients with chronic kidney disease and non-ST-elevation acute coronary syndromes Recommendations for the management of patients with acute heart failure in the setting of non-ST elevation acute coronary syndromes Recommendations for the management of patients with heart failure following non-ST-elevation acute coronary syndromes Recommendations for the management of atrial fibrillation in patients with non-ST-elevation acute coronary syndromes Recommendations for the management of thrombocytopenia in non- ST-elevation acute coronary syndromes Recommendations for long-term management after non-ST-elevation acute coronary syndromes To do and not to do messages from the guidelines THANK YOU